Literature DB >> 20060584

Review: Trophoblast-vascular cell interactions in early pregnancy: how to remodel a vessel.

L K Harris1.   

Abstract

During the first twenty weeks of human pregnancy, extravillous trophoblasts (EVT) colonise the decidua and remodel the uterine spiral arteries as far as the first third of the myometrium. This process leads to an irreversible vasodilatation, ensuring that maximal blood flow is delivered to the materno-fetal interface at an optimal velocity for nutrient exchange. There is accumulating evidence that subtle changes in vascular structure precede EVT colonisation; however, full physiological transformation is only achieved in the presence of trophoblast. This review discusses the mechanisms employed to facilitate arterial dilatation, including recent data regarding the contribution of vascular cell apoptosis, the importance of elastin catabolism and the source of candidate elastases. It also examines how the complex interplay between EVT, endothelial cells, smooth muscle cells and decidual leukocytes (macrophages and uterine natural killer cells) leads to enhanced receptivity to invasion, vascular cell loss and extracellular matrix remodelling. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20060584     DOI: 10.1016/j.placenta.2009.12.012

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  70 in total

1.  Effect of ephrin-A1/EphA2 on invasion of trophoblastic cells.

Authors:  Yun Yang; Jie Min
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

2.  Use of a human embryonic stem cell model to discover GABRP, WFDC2, VTCN1 and ACTC1 as markers of early first trimester human trophoblast.

Authors:  Rowan M Karvas; Samuel McInturf; Jie Zhou; Toshihiko Ezashi; Danny J Schust; R Michael Roberts; Laura C Schulz
Journal:  Mol Hum Reprod       Date:  2020-06-01       Impact factor: 4.025

3.  A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy.

Authors:  Richard D Kenagy; Seung-Kee Min; Eileen Mulvihill; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2011-04-14       Impact factor: 4.268

Review 4.  Paleovirology of 'syncytins', retroviral env genes exapted for a role in placentation.

Authors:  Christian Lavialle; Guillaume Cornelis; Anne Dupressoir; Cécile Esnault; Odile Heidmann; Cécile Vernochet; Thierry Heidmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-08-12       Impact factor: 6.237

5.  Hectd1 is required for development of the junctional zone of the placenta.

Authors:  Anjali A Sarkar; Samer J Nuwayhid; Thomas Maynard; Frederick Ghandchi; Jonathon T Hill; Anthony S Lamantia; Irene E Zohn
Journal:  Dev Biol       Date:  2014-05-20       Impact factor: 3.582

Review 6.  Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy.

Authors:  Michael J Soares; Damayanti Chakraborty; Kaiyu Kubota; Stephen J Renaud; M A Karim Rumi
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 7.  Maternal-fetal conflict, genomic imprinting and mammalian vulnerabilities to cancer.

Authors:  David Haig
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

Review 8.  The placenta: a multifaceted, transient organ.

Authors:  Graham J Burton; Abigail L Fowden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-03-05       Impact factor: 6.237

9.  Association of Placental Jets and Mega-Jets With Reduced Villous Density.

Authors:  Rojan Saghian; Joanna L James; Merryn H Tawhai; Sally L Collins; Alys R Clark
Journal:  J Biomech Eng       Date:  2017-05-01       Impact factor: 2.097

10.  Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies.

Authors:  Zola Chihombori Quao; Mancy Tong; Elena Bryce; Seth Guller; Lawrence W Chamley; Vikki M Abrahams
Journal:  Am J Reprod Immunol       Date:  2017-11-14       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.